From chaos to kaleidoscope: Exploring factors in psychedelic self-treatment for mental health conditions.

IF 4.5 3区 医学 Q1 CLINICAL NEUROLOGY
Journal of Psychopharmacology Pub Date : 2024-08-01 Epub Date: 2024-07-29 DOI:10.1177/02698811241265762
Claire Walker, Timothy Piatkowski, Jason Ferris, Emma Davies, Monica Barratt, Adam Winstock, Cheneal Puljević
{"title":"From chaos to kaleidoscope: Exploring factors in psychedelic self-treatment for mental health conditions.","authors":"Claire Walker, Timothy Piatkowski, Jason Ferris, Emma Davies, Monica Barratt, Adam Winstock, Cheneal Puljević","doi":"10.1177/02698811241265762","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>This study explores how individuals self-treat psychiatric conditions with psychedelics outside medical guidance bridging the gap in understanding unregulated therapeutic use.</p><p><strong>Aims: </strong>The primary objective was to extract specific factors underlying the effects of psychedelics, exploring their relationship with the need for medication, particularly for mental health conditions like depression and anxiety. Additionally, we aimed to understand how the likelihood of being prescribed pharmacological medication varies based on mental health diagnoses and demographic factors.</p><p><strong>Methods: </strong>This research utilised the Global Drug Survey 2020, an annual online survey focused on substance use patterns and demographics, incorporating modules addressing mental health and psychedelic use. The study employed Exploratory Factor Analysis to discern latent factors underlying the self-reported effects of psychedelics. Bivariable and multivariable logistic regressions were conducted to investigate the association between identified factors and the likelihood of current prescribed medication usage.</p><p><strong>Results: </strong>In all, 2552 respondents reported using psychedelics for self-treatment of mental health conditions. Three significant factors were identified: Improved Mental Health, Improved Self-Awareness and Neuro-Sensory Changes. The majority of the sample reported a history of depression (80%) or anxiety (65.6%), with a significant association observed between reported factors of psychedelics' effects and current medication usage for mental health, especially notable in cases of depression or comorbid depression and anxiety.</p><p><strong>Conclusions: </strong>Perceived symptom improvement following psychedelic self-treatment may reduce the need for medically supervised pharmacological interventions. These findings highlight the potential of psychedelics to positively influence mental health and self-awareness, paving the way for further research into their therapeutic application.</p>","PeriodicalId":16892,"journal":{"name":"Journal of Psychopharmacology","volume":" ","pages":"749-760"},"PeriodicalIF":4.5000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11311900/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Psychopharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/02698811241265762","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/29 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: This study explores how individuals self-treat psychiatric conditions with psychedelics outside medical guidance bridging the gap in understanding unregulated therapeutic use.

Aims: The primary objective was to extract specific factors underlying the effects of psychedelics, exploring their relationship with the need for medication, particularly for mental health conditions like depression and anxiety. Additionally, we aimed to understand how the likelihood of being prescribed pharmacological medication varies based on mental health diagnoses and demographic factors.

Methods: This research utilised the Global Drug Survey 2020, an annual online survey focused on substance use patterns and demographics, incorporating modules addressing mental health and psychedelic use. The study employed Exploratory Factor Analysis to discern latent factors underlying the self-reported effects of psychedelics. Bivariable and multivariable logistic regressions were conducted to investigate the association between identified factors and the likelihood of current prescribed medication usage.

Results: In all, 2552 respondents reported using psychedelics for self-treatment of mental health conditions. Three significant factors were identified: Improved Mental Health, Improved Self-Awareness and Neuro-Sensory Changes. The majority of the sample reported a history of depression (80%) or anxiety (65.6%), with a significant association observed between reported factors of psychedelics' effects and current medication usage for mental health, especially notable in cases of depression or comorbid depression and anxiety.

Conclusions: Perceived symptom improvement following psychedelic self-treatment may reduce the need for medically supervised pharmacological interventions. These findings highlight the potential of psychedelics to positively influence mental health and self-awareness, paving the way for further research into their therapeutic application.

从混沌到万花筒:探索迷幻药自我治疗精神疾病的因素。
简介这项研究探讨了个人如何在医疗指导之外使用迷幻药自我治疗精神疾病,弥补了人们在了解不受管制的治疗使用方面的空白。目的:研究的主要目的是提取影响迷幻药作用的具体因素,探讨它们与药物治疗需求的关系,尤其是对抑郁和焦虑等精神疾病的需求。此外,我们还希望了解根据精神健康诊断和人口统计因素开具药物处方的可能性有何不同:这项研究利用了《2020 年全球药物调查》,这是一项关注药物使用模式和人口统计的年度在线调查,其中包含针对精神健康和迷幻药使用的模块。研究采用了探索性因子分析法(Exploratory Factor Analysis)来识别自我报告的迷幻药影响的潜在因素。研究还进行了二变量和多变量逻辑回归,以调查已识别因素与当前处方药使用可能性之间的关联:共有 2552 名受访者表示使用迷幻药自我治疗精神疾病。确定了三个重要因素:改善心理健康、提高自我意识和神经感觉变化。大多数样本报告了抑郁症病史(80%)或焦虑症病史(65.6%),观察到报告的迷幻药影响因素与当前精神健康药物使用之间存在显著关联,尤其是在抑郁症或合并抑郁症和焦虑症的情况下:结论:在进行迷幻药自我治疗后,感觉症状得到了改善,这可能会减少对医疗监督下的药物干预的需求。这些发现凸显了迷幻药对心理健康和自我意识产生积极影响的潜力,为进一步研究迷幻药的治疗应用铺平了道路。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Psychopharmacology
Journal of Psychopharmacology 医学-精神病学
CiteScore
8.60
自引率
4.90%
发文量
126
审稿时长
3-8 weeks
期刊介绍: The Journal of Psychopharmacology is a fully peer-reviewed, international journal that publishes original research and review articles on preclinical and clinical aspects of psychopharmacology. The journal provides an essential forum for researchers and practicing clinicians on the effects of drugs on animal and human behavior, and the mechanisms underlying these effects. The Journal of Psychopharmacology is truly international in scope and readership.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信